Docetaxel for treatment of solid tumours: a systematic review of clinical data - The Lancet Oncology
Mechanism of action of paclitaxel. Paclitaxel targets microtubules. At... | Download Scientific Diagram
Microtubule Active Agents: Beyond the Taxane Frontier | Clinical Cancer Research
Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer: Trends in Pharmacological Sciences
Taxane - Wikipedia
Figure 1 from Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer. | Semantic Scholar
Oncology Nursing Society. Unauthorized reproduction, in part or in whole, is strictly prohibited. For permission to photocopy, post online, reprint, adapt, or otherwise reuse any or all content from this article, e-mail pubpermissions@ons.org. To purchase high ...
Mechanism of Action (MOA) of JEVTANA® (cabazitaxel) Injection
SCHEMATIC REPRESENTATION OF MODE OF ACTION OF TAXANES ON A CANCER CELL.... | Download Scientific Diagram
Paclitaxel; Mechanism of action⑦ - YouTube
Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures - ScienceDirect
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells | SpringerLink
Taxane - Wikiwand
Classical taxane versus the new generation, nab-paclitaxel chemotherapy in the treatment of breast cancer - MedCrave online
The Taxanes, Vinca Alkaloids, and Their Derivatives | Oncohema Key
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies - ScienceDirect
Predicting and Overcoming Taxane Chemoresistance: Trends in Molecular Medicine
Mechanistic representation of Taxane action. Taxane binds to α-tubulin... | Download Scientific Diagram
Figure 1.1 from Cancer Pharmacology and Pharmacotherapy Review: Study Guide for Oncology Boards and MOC Exams | Semantic Scholar
TXR1-mediated thrombospondin repression: a novel mechanism of resistance to taxanes?
JCI - Taxane resistance in prostate cancer is mediated by decreased drug-target engagement
Cancers | Free Full-Text | Mechanisms of Taxane Resistance | HTML
Microtubule Active Agents: Beyond the Taxane Frontier | Clinical Cancer Research
The Taxanes, Vinca Alkaloids, and Their Derivatives | Oncohema Key
